Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
Rhea-AI Summary
Harvard Bioscience (Nasdaq: HBIO) has announced its participation in two major investor conferences in March 2025. The company's leadership team, including Chairman and CEO Jim Green and CFO Jennifer Cote, will attend:
1. The 37th Annual Roth Conference (March 16-18, 2025) at the Laguna Cliffs Marriott Resort in Dana Point, CA. Management will conduct one-on-one meetings and participate in a Fireside Chat on March 17th at 10 a.m. PT.
2. The KeyBanc Capital Markets Healthcare Forum, a virtual event on March 19, 2025, featuring one-on-one meetings and a Fireside Chat with Paul Knight at 3:45 p.m. ET.
Both events will be webcast live on the company's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, HBIO declined 6.55%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025:
- The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17th, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO’s website at https://investor.harvardbioscience.com/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact oneonone@roth.com.
- The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March 19, 2025. Management will host one-on-one meetings and is also scheduled for a Fireside Chat with Paul Knight, KeyBanc Capital Markets, on the same day starting at 3:45 p.m. ET. The live webcast is available on HBIO’s website at https://investor.harvardbioscience.com/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact kbcmhealthcareconferenceteam@key.com.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at www.harvardbioscience.com
Company Contact:
Harvard Bioscience
Jennifer Cote, Chief Financial Officer
(508) 893-3120
Investor Contacts:
Three Part Advisors
Sandy Martin / Erol Girgin
HBIO@threepa.com
(214) 616-2207
FAQ
When is Harvard Bioscience (HBIO) presenting at the Roth Conference in March 2025?
How can investors watch HBIO's March 2025 conference presentations?
What investor conferences is HBIO attending in March 2025?
How can investors schedule one-on-one meetings with HBIO management at these conferences?
Which HBIO executives are participating in the March 2025 investor conferences?
